Atorvastatina Davur is taken once a day. The medication can be taken at any time of the day, with or without food. Remember to follow a special diet and change your lifestyle during treatment with Atorvastatina Davur.
The initial dose is based on the level of cholesterol and the treatment goal. The initial normal dose is 10 mg per day. Your doctor may increase this dose after 4 weeks or more if necessary.
The maximum dose is 80 mg once a day.
The daily dose should be taken in a single dose.
Your doctor will determine the duration of treatment with Atorvastatina Davur. Ask your doctor if you think the effect of atorvastatina is too strong or too weak.
Liver Insufficiency
Atorvastatina Davur should be used with caution in patients with liver insufficiency and is contraindicated in patients with active liver disease.
Children and Adolescents (4-17 years)
The use of Atorvastatina Davur in children should be carried out under strict supervision of a specialist.
If You Take More Atorvastatina Davur Than You Should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If You Forget to Take Atorvastatina Davur
If you have forgotten to take a dose, take it as soon as possible. However, if it is almost time to take the next dose, omit the missed dose and take the next one when it is due.
Do not take a double dose to compensate for the missed doses.
If You Interrupt Treatment with Atorvastatina Davur
If you have any other doubts about the use of this medication, ask your doctor, pharmacist, or nurse.
The following side effects are serious and if you experience any of them, you will need to take immediate action. Stop taking Atorvastatina Davur and see your doctor immediately if you experience the following symptoms:
Very rare side effects (may affect fewer than 1 in 10,000 patients):
- if you experience unexpected or unusual bleeding or bruising, this may suggest a liver problem. You should consult your doctor as soon as possible.
The following side effects have also been reported:
Frequent side effects (may affect between 1 and 10 in 100 patients): abdominal pain, constipation, gas, indigestion, nausea, diarrhea, allergic reactions, difficulty sleeping, headache, dizziness, numbness or tingling in the hands and feet, reduced sensitivity to touch or pain, rash, itching, muscle and joint pain, weakness, chest pain, back pain, and inflammation of the hands and feet.
Rare side effects (may affect between 1 and 10 in 1,000 patients):loss of appetite, vomiting, muscle cramps, unexpected bleeding or bruising due to low platelet count, hair loss, pancreatitis (inflammation of the pancreas causing stomach pain), urticaria, skin rash, memory loss, ringing or buzzing in the ears, discomfort, weight gain, impotence, increased and decreased blood sugar levels (if you have diabetes, you should have strict control of your blood sugar levels).
Rare side effects (may affect between 1 and 10 in 10,000 patients):muscle pain on palpation, liver inflammation (hepatitis), yellowing of the skin and white of the eyes (jaundice), rhabdomyolysis (severe muscle pain and weakness often associated with fever):
Very rare side effects (may affect fewer than 1 in 10,000 patients):
angioneurotic edema (swelling of the face, tongue, and throat that can cause great difficulty breathing), Stevens-Johnson syndrome (a serious disease with blisters on the skin, mouth, eyes, and genitals), erythema multiforme (irregular rash with red spots),vision and taste disorders, hearing loss, breast enlargement in men (gynecomastia), tendon fractures, liver failure.
Side effects of unknown frequency:
constant muscle weakness.
Myasthenia gravis (a disease that causes generalized muscle weakness that, in some cases, affects the muscles used for breathing).
Myasthenic eye (a disease that causes weakness of the eye muscles).
Consult your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision or eyelid drooping, difficulty swallowing or difficulty breathing
Other possible side effects:
•Sleep disorders, including insomnia and nightmares
•Memory loss
•Sexual dysfunction
•Depression
•Respiratory problems, including persistent cough and/or difficulty breathing or fever
•Diabetes. It is more likely if you have high blood sugar and fat levels, obesity, and high blood pressure. Your doctor will monitor you while you are taking this medication.
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Store below30°C.
Do not use Atorvastatina Davur after the expiration date that appears on the packaging after“CAD”. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medicines at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medicines. By doing so, you will help protect the environment.
Composition of Atorvastatina Davur
The active ingredient is atorvastatina. Each tablet contains 30 mg of atorvastatina as atorvastatina calcium.
The other components are:
Appearance of the product and contents of the packaging
Film-coated tablets.
The tablets are white or almost white, elliptical, biconvex, and marked with “30” on one side.
The packaging contains 28 tablets.
Holder of the marketing authorization
Teva Pharma, S.L.U.
C/ Anabel Segura, 11 - Edificio Albatros B, 1st floor.
28108 – Alcobendas (Madrid)
Responsible for manufacturing
Teva Pharma, S.L.U.
Polígono Malpica, Calle C nº 4.
50016 Zaragoza. Spain.
Date of the last review of this leaflet:November 2024
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.